International Journal of Cancer Management

Published by: Kowsar

Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women

Shahpar Haghighat 1 , 2 , Mohammad Esmaeil Akbari 3 , Parvin Yavari 2 , 4 , Mehdi Javanbakht 5 and Shahram Ghaffari 6 , *
Authors Information
1 Breast Cancer Research Center (BCRC), ACECR, Tehran, IR Iran
2 Epidemiology Department, School of Public Health, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, IR Iran
3 Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences (SBMU), Tehran, IR Iran
4 Department of Health and Community Medicine, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, IR Iran
5 Health Economics Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
6 Iranian Social Security Organization, Tehran, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: February 2016, 9 (1); e5443
  • Published Online: February 23, 2016
  • Article Type: Research Article
  • Received: January 27, 2016
  • Accepted: January 31, 2016
  • DOI: 10.17795/ijcp-5443

To Cite: Haghighat S, Akbari M E, Yavari P, Javanbakht M, Ghaffari S. Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women, Int J Cancer Manag. 2016 ; 9(1):e5443. doi: 10.17795/ijcp-5443.

Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Astim E. Cost-effectiveness analysis of a prospective breast cancer screening program in Turkey 2011;
  • 2. 2010;
  • 3. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007; 13(4): 383-91[DOI][PubMed]
  • 4. Harirchi I, Kolahdoozan S, Karbakhsh M, Chegini N, Mohseni SM, Montazeri A, et al. Twenty years of breast cancer in Iran: downstaging without a formal screening program. Ann Oncol. 2011; 22(1): 93-7[DOI][PubMed]
  • 5. Akbari ME, Haghighatkhah H, Shafiee M, Akbari A, Bahmanpoor M, Khayamzadeh M. Mammography and ultrasonography reports compared with tissue diagnosis--an evidence based study in Iran, 2010. Asian Pac J Cancer Prev. 2012; 13(5): 1907-10[PubMed]
  • 6. Warner E. Clinical practice. Breast-cancer screening. N Engl J Med. 2011; 365(11): 1025-32[DOI][PubMed]
  • 7. Barfar E, Rashidian A, Hosseini H, Nosratnejad S, Barooti E, Zendehdel K. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women. Arch Iran Med. 2014; 17(4): 241-5[PubMed]
  • 8. Barfar E, Rashidiyan A, Zendehdel AS. Cost-effectiveness of mammograghy breast Cancer screening in Vulnerable Household Women. TUMS. 2011;
  • 9. Breast cancer screening of ministry of health and medical education women staff 2002;
  • 10. TETO . Breast cancer screening of Tehran cities female teachers. Tehran 2004;
  • 11. Iran National Census of population and housing 2011;
  • 12. Iranian annual cancer registration report 2012;
  • 13. Wallis M, Neilson F, Hogarth H, Whitaker C, Faulkner K. Cumulative attendance, assessment and cancer detection rate over four screening rounds in five English breast-screening programmes: a retrospective study. J Public Health (Oxf). 2007; 29(3): 275-80[DOI][PubMed]
  • 14. NHS Breast Screening Programme Annual Review 2012, Overcoming barriers 2012;
  • 15. Barooti E, Haghdoost AA, Hosseini H, Tabibzadeh Z, Bahmani S, Taheri S, et al. Vulnerable household women’s health assessment (VH-WHAT): protocol design and implementation. IRCMJ. 2010; 2010(4): 358-64
  • 16. Haghighat S, Akbari ME, Ghaffari S, Yavari P. Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev. 2012; 13(11): 5525-8[PubMed]
  • 17. Vostakolaei FA, Broeders MJ, Rostami N, van Dijck JA, Feuth T, Kiemeney LA, et al. Age at diagnosis and breast cancer survival in iran. Int J Breast Cancer. 2012; 2012: 517976[DOI][PubMed]
  • 18. Akbari ME, Khayamzadeh M, Khoshnevis SJ, Nafisi N, Akbari A. Five and ten years survival in breast cancer patients mastectomies vs. breast conserving surgeries personal experience. IJCP. 2012; 1(2): 53-6
  • 19. Saeedi Saedi H, Ghavam Nasiri MR, ShahidSales S, Taghizadeh A, Mohammadian N. Comparison of hormone receptor status in primary and recurrent breast cancer. Iran J Cancer Prev. 2012; 5(2): 69-73[PubMed]
  • 20. Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM. Cost effectiveness of mammography screening for Chinese women. Cancer. 2007; 110(4): 885-95[DOI][PubMed]
  • 21. Iranian annual report of death registration 2006 deputy for health 2007;
  • 22. Movahedi M, Haghighat S, Khayamzadeh M, Moradi A, Ghanbari-Motlagh A, Mirzaei H, et al. Survival rate of breast cancer based on geographical variation in iran, a national study. Iran Red Crescent Med J. 2012; 14(12): 798-804[DOI][PubMed]
  • 23. Tarrif of diagnistic and therapeutic services 2012;
  • 24. Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, et al. Making choices in health: WHO guide to cost-effectiveness analysis 2003;
  • 25. Cost-effectiveness thresholds ,. 2013;
  • 26. Whelehan P, Evans A, Wells M, Macgillivray S. The effect of mammography pain on repeat participation in breast cancer screening: a systematic review. Breast. 2013; 22(4): 389-94[DOI][PubMed]
  • 27. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. The Lancet. 2002; 359(9310): 909-19[DOI]
  • 28. Foca F, Mancini S, Bucchi L, Puliti D, Zappa M, Naldoni C, et al. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy. Cancer. 2013; 119(11): 2022-8[DOI][PubMed]
  • 29. van den Akker‐van Marle ME, Reep‐van den Bergh CMM, Boer R, Del Moral A, Ascunce N, de Koning HJ. Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round. Int J Cancer. 1997; 73(4): 464-9[DOI]
  • 30. Fielder H, Rogers C, Gower-Thomas K, Monypenny I, Dallimore N, Brook D, et al. Results from 10 years of breast screening in Wales. J Med Screen. 2001; 8(1): 21-3[PubMed]
  • 31. Heydari S, Mehrabani D, Tabei SZ, Azarpira N, Vakili MA. Survival of breast cancer in southern Iran. IJCP. 2012; 2(1): 51-4
  • 32. Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med. 1997; 127(11): 955-65[PubMed]
  • 33. Ross A, Salzmann M, Senn H. Fast-HMQC using Ernst angle pulses: An efficient tool for screening of ligand binding to target proteins. J Biomol NMR. 1997; 10(4): 389-96[DOI][PubMed]
  • 34. Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst. 2008; 100(18): 1290-300[DOI][PubMed]
  • 35. Coldman A, Phillips N. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program. Can Med Assoc J . 2013; 185(10)-8
  • 36. Prasad V, Lenzer J, Newman DH. Why cancer screening has never been shown to "save lives"-and what we can do about it. BMJ. 2016; 352[DOI][PubMed]
  • 37. Gotzsche PC, Jorgensen KJ, Gotzsche PC. Screening for breast cancer with mammography. 2013; [DOI]
  • 38. Lidgren M, Wilking N, Jonsson B. Cost of breast cancer in Sweden in 2002. Eur J Health Econ. 2007; 8(1): 5-15[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments